Live Longer sans the AT1A Receptor

Slides:



Advertisements
Similar presentations
Ligand Receptor Cortisol Receptor is located in the cytosol Retinoid Receptors are in the nucleus Target gene in the nucleus Regulation of Transcription.
Advertisements

Signal Transduction Biochemistry – February 23, 2005 Chapter 12 – parts 12.3, 12.4.
CGMP Intracellular Signal cGMP is made from GTP by the enzyme gaunylyl cyclase. Atrial natriuretic peptide and nitric oxide function through this Signal.
Chapter 14. Signal Transduction Signal transduction is the process by which an extracellular signal alters intracellular events. 1. First and second messengers.
An Introduction to Medicinal Chemistry 3/e PROTEINS AS DRUG TARGETS:
Introduction to Receptors
The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease  Konrad Talbot, Hoau-Yan Wang 
Alexander Loewer, Galit Lahav  Cell 
From: Narrative Review: The Emerging Clinical Implications of the Role of Aldosterone in the Metabolic Syndrome and Resistant Hypertension Ann Intern Med.
Cell Signaling.
OVERVIEW: Signals for cell surface receptors (hydrophilic):
Akihito Muto, MD, PhD, Tamara N. Fitzgerald, MD, PhD, Jose M
Eph-Ephrin Bidirectional Signaling in Physiology and Disease
Sustaining Proliferative Signaling and Evading Growth Suppressors
Temporal Bias: Time-Encoded Dynamic GPCR Signaling
Patrick Delmas, Bertrand Coste, Nikita Gamper, Mark S. Shapiro  Neuron 
You have identified a novel cytoplasmic protein
HFpEF, a Disease of the Vasculature: A Closer Look at the Other Half
Volume 47, Issue 1, Pages (July 2007)
Insulin Secretion: Fatty Acid Signalling via Serpentine Receptors
The Incretins and β-Cell Health: Contrasting Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 as a Path to Understand Islet Function.
Primary Immunodeficiencies
Volume 23, Issue 3, Pages (March 2016)
Signal Transduction Through the Epidermal Growth Factor Receptor
by Walter Zumkeller, and Stefan Burdach
Figure 2 Oestrogen receptor signalling pathways
Mechanisms of mast cell signaling in anaphylaxis
A Flt3L Encounter: mTOR Signaling in Dendritic Cells
Ding Ai, John Y.-J. Shyy, Yi Zhu  Kidney International 
The marriage of glucose and blood vessels: It isn’t all that sweet
Development of PI3K/AKT/mTOR Pathway Inhibitors and Their Application in Personalized Therapy for Non–Small-Cell Lung Cancer  Vassiliki Papadimitrakopoulou,
Vascular dysfunction in diabetes mellitus
Great Expectations for PIP: Phosphoinositides as Regulators of Signaling During Development and Disease  Lara C. Skwarek, Gabrielle L. Boulianne  Developmental.
PTEN Enters the Nuclear Age
Figure 1 The insulin signalling pathway
Inhibition of mammalian target of rapamycin: Two goals with one shot?
Rapamycin: One Drug, Many Effects
Enyu Imai, Hideaki Nakajima, Jun-Ya Kaimori  Kidney International 
mTORC1 Signaling: A Double-Edged Sword in Diabetic β Cells
Selective Insulin and Leptin Resistance in Metabolic Disorders
Chapter 14 Blood Pressure – Regulation and Pathology
Gabriel Mitchell, Ralph R. Isberg  Cell Host & Microbe 
Volume 18, Issue 1, Pages (July 2013)
Estrogen Receptors and the Metabolic Network
Inflammation and Lipid Signaling in the Etiology of Insulin Resistance
GDF11 and the Mythical Fountain of Youth
Volume 70, Issue 10, Pages (November 2006)
The Two Sides of Hippocampal Mossy Fiber Plasticity
Signal Transduction Through the Epidermal Growth Factor Receptor
AKT/PKB Signaling: Navigating Downstream
p38δ and PKD1: Kinase Switches for Insulin Secretion
Rapamycin: One Drug, Many Effects
Temporal Bias: Time-Encoded Dynamic GPCR Signaling
Insulin Resistance in the Defense against Obesity
Yan Feng, MD, Praveena S. Thiagarajan, PhD, Patrick C. Ma, MD 
Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways
Jinhua Tang, Na Liu, Shougang Zhuang  Kidney International 
Brian K. Kennedy, Dudley W. Lamming  Cell Metabolism 
Eric N. Johnson, PhD, Kirk M. Druey, MD 
The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease  Konrad Talbot, Hoau-Yan Wang 
The complex field of interplay between vasoactive agents
Using Exercise to Measure and Modify Cardiac Function
Macrophages, Immunity, and Metabolic Disease
Stanley Nattel JACEP 2017;3:
Yiannis S. Chatzizisis et al. JACC 2007;49:
Cell Signaling by Receptor Tyrosine Kinases
Connections between insulin/insulin-like growth factor 1 signaling and metabolic pathways in tumor cells. Connections between insulin/insulin-like growth.
NF-κB, Inflammation, and Metabolic Disease
Airway smooth muscle: An immunomodulatory cell
Christian Rask-Madsen, George L. King  Cell Metabolism 
Presentation transcript:

Live Longer sans the AT1A Receptor Mark P. Mattson, Stuart Maudsley  Cell Metabolism  Volume 9, Issue 5, Pages 403-405 (May 2009) DOI: 10.1016/j.cmet.2009.04.002 Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 1 AT1AR Signaling Pathways That May Mediate Effects of Ang II on Age-Related Disease Etiology and Eventual Longevity The angiotensin receptor (AT1R) is coupled to the GTP-binding protein Gq. One major downstream pathway involves protein kinase C-δ (PKCδ) Rho-GEF (guanine exchange factor) and RhoA, resulting in the activation of ROCK (Rho-kinase). ROCK can promote inflammation by inducing the expression of the chemokine monocyte chemoattractant protein-1 (MCP-1) and can also stimulate cell hypertrophy and migration by activating JNK (c-jun N-terminal kinase). In addition, ROCK promotes the contraction of vascular smooth muscle cells via a kinase cascade that activates myosin light chain (MLC), which may contribute to hypertension and vascular pathology. Activation of the AT1AR can also induce free radical (superoxide and peroxynitrite) production by stimulating membrane-associated NADPH oxidase. The resulting ROS can cause oxidative damage to DNA, proteins, and lipids and can also activate the transcription factor NF-κB, which induces the expression of proinflammatory cytokines. Activation of AT1R coupled to Gαq11 causes membrane inositol phospholipid (PIP2) hydrolysis, generating inositol trisphosphate (IP3), which triggers Ca2+ release from endoplasmic reticulum stores. This Ca2+ release then activates matrix metalloproteases such as ADAM17, which cleaves heparin-binding epidermal growth factor (EGF) on the cell surface, releasing EGF—which binds and then activates EGF receptor tyrosine kinase activity (TK). Receptors for the EGF receptor, and the insulin and insulin-like growth factor (IGF) receptors, are coupled to intracellular adaptor proteins (Shc, Grb2, and Sos in the case of the EGF receptor, and IRS1 in the case of the insulin/IGF receptor) that activate the monomeric G protein Ras. Activation of these growth factor receptors can also lead to activation of phosphatidylinositol-3 kinase (PI3K), which in turn can activate Akt kinase. Downstream targets of Akt that may mediate effects of AT1AR on cellular aging include forkhead transcription factors (FHTF) and the mammalian target of rapamycin (mTOR). Figure prepared by KC Alexander. Cell Metabolism 2009 9, 403-405DOI: (10.1016/j.cmet.2009.04.002) Copyright © 2009 Elsevier Inc. Terms and Conditions